WO2024240923 - PREBIOTICS FOR TREATING AND/OR PREVENTING VITAMIN K2 DEFICIENCY
National phase entry is expected:
Publication Number
WO/2024/240923
Publication Date
28.11.2024
International Application No.
PCT/EP2024/064337
International Filing Date
24.05.2024
Title **
[English]
PREBIOTICS FOR TREATING AND/OR PREVENTING VITAMIN K2 DEFICIENCY
[French]
PRÉBIOTIQUES POUR LE TRAITEMENT ET/OU LA PRÉVENTION D'UNE DÉFICIENCE EN VITAMINE K2
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Avenue Nestlé 55
1800 VEVEY, CH
Inventors
BOULANGE, Claire Laurence Lucie Marie
Chemin des Chênes 3
1610 Oron la Ville, CH
DUBOUX, Stéphane
90, Chemin de la Damaz
1162 St-Prex, CH
CAMPOS GIMENEZ, Esther
Chemin de la Bioleyre 29
1681 Billens, CH
HORCAJADA, Marie Noëlle
168, Rue de la Pierre
01170 Echenevex, FR
BONNET, Nicolas
385 rue Beaupré
74160 Beaumont, FR
Priority Data
23175289.0
25.05.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1350 | |
| EPO | Filing, Examination | 6176 | |
| Japan | Filing | 530 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2635 |
Total: 11266 USD
Abstract[English]
The present invention relates to a prebiotic agent for use in treating and/or preventing vitamin K2 deficiency in a subject. The present invention relates to the use of a prebiotic agent to promote vitamin K2 production in the gut of a subject.[French]
La présente invention concerne un agent prébiotique destiné à être utilisé dans le traitement et/ou la prévention d'une déficience en vitamine K2 chez un sujet. La présente invention concerne l'utilisation d'un agent prébiotique pour favoriser la production de vitamine K2 dans l'intestin d'un sujet.